A comprehensive view of Non-Vaccine Biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Thermo Fisher partners with Celltrio to integrate Thermo Scientific Momentum workflow scheduling software with Celltrio RoboCell cell line automation platform in Europe; system offers high-throughput automated cell line culturing and maintenance

Lotte Biologics to invest US$3.0B by 2030 to build three mega plants in South Korea with total capacity of 360,000 liters of antibody drugs; commercial production to start in 2027 and all three plants to be fully operational by 2034

Pfizer Listed a New Clinical Trial to Understand Long-term Safety and Effects of Fordadistrogene Movaparvovec Experimental Gene Therapy for Duchenne Muscular Dystrophy

Merck wraps up US$1.35B deal for US-based Imago Biosciences; Imago to become wholly-owned subsidiary of Merck

Autobahn Therapeutics announces initiation of a Phase 1 clinical trial of ABX-002 for the treatment for major depressive disorder; ABX-002 is a selective brain-boosting thyroid receptor beta agonist

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count